EGFR with TKI-sensitive mutations in exon 19 is highly expressed and frequently detected in Chinese patients with lung squamous carcinoma

Podobné jednotky

• Association between EGFR exon 19 or exon 21 mutations and survival rates after first-line EGFR-TKI treatment in patients with non-small cell lung cancer
  Autor: Jiang, Haiying, a další
  Vydáno: (2019)
• EGFR-TKI-sensitive mutations in lung carcinomas: are they related to clinical features and CT findings?
  Autor: Qin X, a další
  Vydáno: (2018-10-01)
• EGFR-TKI-sensitive mutations in lung carcinomas: are they related to clinical features and CT findings?
  Autor: Qin, Xiaoyi, a další
  Vydáno: (2018)
• Synergistic interaction between sorafenib and gemcitabine in EGFR-TKI-sensitive and EGFR-TKI-resistant human lung cancer cell lines
  Autor: LI, JING, a další
  Vydáno: (2013)
• Identification of exon 19 and 21 mutations of EGFR gene in Chinese patients with esophageal squamous cell carcinoma
  Autor: Cui, Yong, a další
  Vydáno: (2013)